Valvular Heart Disease/Cardiac Surgery

Journal of the American College of Cardiology

Volumn 47, Issue 11 SUPPL., 2006, Pages

  Rahimtoola, Shahbudin H ^a  

^a Griffith Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; STREPTOKINASE;

AORTA STENOSIS; BACTERIAL ENDOCARDITIS; CLINICAL TRIAL; HEART SURGERY; HEART VALVE PROSTHESIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTATION; MITRAL VALVE REGURGITATION; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS; REVIEW; THROMBOSIS; VALVULAR HEART DISEASE;

CARDIAC SURGICAL PROCEDURES; HEART VALVE DISEASES; HUMANS;

EID: 33744528573     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.04.042     Document Type: Review

References (37)

1. Shoob H., Croft J., Ayala C., and Mensah G. Valvular heart disease surveillance in the United States, 1980-2000. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 276A
2. Rajamannan N., Caira F., Stock S., et al. Human degenerative valve disease is associated with upregulation of Lrp5 receptor mediated bone formation. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 284A
3. Cachier A., Iung B., Messika-Zeitoun D., et al. Are there gender-related differences in presentation and management of patients with severe aortic stenosis?. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 286A
4. Feng D., Ramakrishna G., Sarano M., Baron T., Pellika P., and Maloug J. Aortic valve replacement in patients with moderate to severe aortic stenosis does not prevent bleeding from gastrointestinal arteriovenous malformations. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 286A
5. Bruch C., Kauling D., Reinecke H., Rothenburger M., and Wichter T. Comorbidities in severe aortic valve stenosis. do renal dysfunction, anemia or diabetes mellitus predict long-term outcome?. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 287A
6. Koos R., Kuehl H., Manken A., et al. Association of low fetuin-A and inflammation with the severity of aortic valve calcification (AVC). (abstr). J Am Coll Cardiol 47 Suppl A (2006) 287A
7. Katz R., Wong N., Budoff M., et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcifications as detected by electron beam computed tomography in the multi-ethnic study of atherosclerosis. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 287A
8. Michelena H., Nkomo V., Desjardins V., Tajik A., and Enriquez-Sarano M. Long-term outcome of asymptomatic bicuspid aortic valve in the community. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 276A
9. Farzaneh-Far A., Roman M., Lockshin M., Devereux R., Paget S., and Crow M. Impact of antiphospholipid antibodies on cardiovascular disease in systemic lupus erythematosus. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 277A
10. Adawi S., Aviram S., Lewis B., and Shiran A. Is myxomatous mitral valve disease the leading cause of partially flail mitral valve leaflet and ruptured chordae?. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 278A
11. Polain de Waroux J., Pouleur A.N., Benedicte B., et al. Survival after coronary revascularization, with and without mitral valve repair, in patients with ischemic mitral regurgitation. Importance of pre-operative myocardial viability. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 278A
12. Cachier A., Iung B., Messika-Zeitoun D., Tornos P., Himbert D., and Butchart E. Clinical presentation and management of patients with severe mitral regurgitation. are there differences between men and women?. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 279A
13. Enriquez-Sarano M., Messika-Zeitoun D., Detain D., Avierinos J., Nkomo V., and Tajik J. Effect of angiotensin blockade on the degree of organic mitral regurgitation. a randomized clinical trial. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 279A
14. Supino P., Borer J., Hocheiter C., Herrold E.McM., Preibisz J., and Kligfield P. Preoperative exercise capacity predicts survival and persistent symptoms after surgery for chronic nonischemic mitral regurgitation. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 279A
15. Thompson E., Goldstein S., Fuisz A., Mark A., Laureno R., and Lin M. Prospective determination of the prevalence of clinically unapparent cerebral embolization in patients with left-sided infective endocarditis. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 280A
16. Liao L., Kong D., Samad Z., et al. Echocardiographic risk-stratification for early surgery in patients with endocarditis is a cost-attractive alternative to standard care. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 280A
17. Movahed M., Hashemzadeh M., and Jamal M. Infectious endocarditis is independently associated with type II diabetes mellitus. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 281A
18. Anavekar N.S., Anavekar N.S., Tleyjeh I., et al. Baseline characteristics associated with embolism in infective endocarditis. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 281A
19. Rogers J., Macoviak J., Takeda P., Rahdert D., and Low R. Percutaneous Septal Sinus Shortening (the PS3 System) ameliorates functional mitral regurgitation. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 282A
20. Block P., Hermann H., Whitlow P., et al. Percutaneous edge-to-edge mitral valve repair using the Evalve MitraClip. initial experience with functional mitral regurgitation in the EVEREST I trial. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 283A
21. Krasuski R., Wang A., Kisslo K., Harrison K., and Bashore T. Pulmonary hypertension with excessive transpulmonary gradients among mitral stenotics. prevalence and clinical outcome following percutaneous balloon mitral commissurotomy. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 283A
22. Hanzel G., Abbas A., Dixon S., et al. The incidence of aortic regurgitation after percutaneous aortic valve implantation. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 283A
23. Dumont E., Gillinor A.M., Blackston E.H., Rajeswaran J., Colafranceshi S., and Mihaljeric T. Functional ischemic mitral regurgitation. impact of left ventricular function on outcome. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 272A
24. Daimon M., Fukuda S., Adams D., et al. Mitral valve repair with a novel etiology-specific annuloplasty ring for ischemic mitral regurgitation. early echocardiography results from a multi-center study. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 272A
25. Russo A., Freeman M., Sundt T., Brown Jr. R., and Sarano M. Cerebrovascular thromboembolic events after mitral valve repair. implication for treatment of patients with mitral regurgitation. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 273A
26. Fukuda S., Gillinov M., McCarthy P., et al. Initial experience of new three-dimensional annuloplasty ring for functional tricuspid regurgitation. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 273A
27. Schelbert E., Vaughan-Sarrazin M., Welke K., and Rosenthal G. Valve type and long term outcomes after aortic valve replacement in older patients. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 281A
28. Omar Sr. A.K. Thrombolytic therapy for left-sided prosthetic valve thrombosis. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 285A
29. Karthikevan G., Mathew N., Kalaivani M., Singh S., Math R., and Shankar B. A prospective randomized trial of a rapid fibrinolytic protocol for left-sided prosthetic valve thrombosis. interim analysis. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 277A
30. Mohan S., Kohsaka S., Contreras A., et al. Prosthesis-patient mismatch affects long-term survival after mechanical aortic valve replacement. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 282A
31. Kaple R., Murphy R., York A., et al. Mitral valve abnormalities in patients undergoing myectomy. echocardiographic features, surgical therapies and outcomes. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 273A
32. Smedira N.G., Lever H.M., Miluk M., et al. Septal myectomy. 324 consecutive procedures without mortality. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 275A
33. Iung B., Mirabel M., Messika-Zeiton D., et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 272A
34. Mehta R., Grab J., O'Brien S., et al. Bedside tool to predict of postoperative dialysis. results in 358,296 patients undergoing coronary bypass surgery. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 274A
35. Guru V., Fremes S., and Tu J. The long-term outcomes of patients with severe left ventricular dysfunction following coronary artery bypass graft (CABG) surgery. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 276A
36. Rampoldi V., Trimarchi S., Eagle A., et al. Simple risk model to predict surgical mortality in acute type a aortic dissection. the IRAD score. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 274A
37. Brizzio M.E., Blackstone E.H., Krishna Seramy G., and Lauer M.S. Short- and long-term outcomes of cardiac surgery for observant Jehovah Witnesses. (abstr). J Am Coll Cardiol 47 Suppl A (2006) 275A